Modern hybrid molecular imaging technologies allow you to detect specific disorders of metabolism (glucose, choline, methionine, etc.) and receptor activity (receptors of somatostatin, estrogen, androgen, etc.) and provide early detection, determination of the phase of development and prognosis of the disease, selection of treatment as "key to the lock," programs of personalized treatment and rehabilitation, including an assessment of the prediction of effectiveness and safety.